Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer, Executive Vice President, Research & Development

Overview

Rebecca Taub made an average of $2.4M in compensation at Synta Pharmaceuticals from 2016 to 2018.

Annual data

2018

In 2018, Rebecca Taub earned a total compensation of $4.3M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals.

Ranking2,058 out of 10,778
Percentile80.9%

Rebecca Taub's 2018 compensation ranked 2,058th out of 10,778 executive pay records tracked by us this year.

Taub earned more than 80.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking198 out of 1,199
Percentile83.5%

In the industry group of Drugs, Taub's pay ranked 198th out of 1,199 executive pay records tracked by us in 2018.

Taub earned more than 83.5% of executives in this group.

Non-Equity Incentive Plan$225,330
Option Awards$3,729,700
Salary$385,416
Total$4,340,446

Taub received $3.7M in option awards, which accounts for 85.93% of total compensation.

Taub also received $225.3K in non-equity incentive plan and $385.4K in salary.

Rebecca Taub's Pay$4,340,446
Median Employee's Pay$804,000
Pay Ratio5 : 1

For fiscal year 2018, the annual total compensation for Rebecca Taub was $4,340,446 and for the median employee at Synta Pharmaceuticals was $804,000. The resulting ratio of Rebecca Taub's pay to the pay of median employee was 5 to one.

2017

In 2017, Rebecca Taub earned a total compensation of $1.1M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals.

Ranking8,056 out of 13,701
Percentile41.2%

Rebecca Taub's 2017 compensation ranked 8,056th out of 13,701 executive pay records tracked by us this year.

Taub earned more than 41.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking799 out of 1,547
Percentile48.4%

In the industry group of Drugs, Taub's pay ranked 799th out of 1,547 executive pay records tracked by us in 2017.

Taub earned more than 48.4% of executives in this group.

Bonus$247,900
Salary$370,000
Stock Awards$473,337
Other$558
Total$1,091,795

Taub received $473.3K in stock awards, which accounts for 43.35% of total compensation.

Taub also received $247.9K in bonus, $370K in salary and $558 in other compensation.

2016

In 2016, Rebecca Taub earned a total compensation of $1.7M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals.

Ranking5,774 out of 14,021
Percentile58.8%

Rebecca Taub's 2016 compensation ranked 5,774th out of 14,021 executive pay records tracked by us this year.

Taub earned more than 58.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking502 out of 1,495
Percentile66.4%

In the industry group of Drugs, Taub's pay ranked 502nd out of 1,495 executive pay records tracked by us in 2016.

Taub earned more than 66.4% of executives in this group.

Bonus$62,160
Option Awards$1,139,272
Salary$162,705
Stock Awards$289,416
Other$465
Total$1,654,018

Taub received $1.1M in option awards, which accounts for 68.88% of total compensation.

Taub also received $62.2K in bonus, $162.7K in salary, $289.4K in stock awards and $465 in other compensation.